Showing results (1611-1620 of 3,204) with videos related to

Sort By:
Pageof 321
Molecular Cancer Therapeutics|July 1, 2018
Arsenic Trioxide and Sorafenib Induce Synthetic Lethality of FLT3-ITD Acute Myeloid Leukemia CellsRui Wang, Ying Li, Ping Gong, et al.
Cells|April 12, 2022
The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer CellsNisha Rani Dahiya, Boris A Leibovitch, Rama Kadamb, et al.
Behavioral Healthcare Tomorrow|February 7, 1994
The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatmentR Geraty, J Bartlett, E Hill, et al.
Cancer|February 1, 1994
Combined choriocarcinoma and yolk sac tumor arising in Barrett's esophagusH S Wasan, J B Schofield, T Krausz, et al.
The American Surgeon|October 1, 1995
The effect of Polyethylene Glycol-Superoxide Dismutase on gastric mucosa and survival in shock with tissue injuryG T Tominaga, S Bailey, K Daughters, et al.
Clinical Immunology and Immunopathology|February 1, 1984
Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptorJ B Cornacoff, L A Hebert, D J Birmingham, et al.
The American Journal of Cardiology|December 1, 1983
Identifying patients at risk of sudden death after myocardial infarction: value of the response to programmed stimulation, degree of ventricular ectopic activity and severity of left ventricular dysfunctionF E Marchlinski, A E Buxton, H L Waxman, et al.
Circulation|November 1, 1980
Effects of respiration and posture on paroxysmal supraventricular tachycardiaM B Waxman, J F Bonet, J P Finley, et al.
The American Journal of Cardiology|March 1, 1983
Disopyramide: evaluation of electrophysiologic effects and clinical efficacy in patients with sustained ventricular tachycardia or ventricular fibrillationB B Lerman, H L Waxman, A E Buxton, et al.
The American Journal of Cardiology|November 1, 1983
Electrophysiologic studies in nonsustained ventricular tachycardia: relation to underlying heart diseaseA E Buxton, H L Waxman, F E Marchlinski, et al.
Pageof 321